July 2020 updates to the website
16 July 2020
The website has now been updated following July's LSCMMG
The following Drugs have been added/updated:
Fremanezumab - For preventing migraine (TA 631)
Ustekinumab - For treating moderately to severely active ulcerative colitis (TA 633)
Avatrombopag - For treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA 626)
The following guidelines have been added/updated:
Guidelines for the prescribing of nutritional supplements post bariatric surgery - Position Statement - Update
Assessing suitability for strong Opioid use pathway - Guidance - New
The following Items will be ratified and added to the website following Joint Committee of CCGs (JCCCG) Meeting:
Rifaximin - Second line antibacterial treatment for the treatment of Small Intestinal Bacterial Overgrowth
Linezolid - Pneumonia, skin and soft-tissue infections
Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway - Update
Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy - Update